Rang	Name	Position
1	Mr. Stéphane Bancel M.B.A.	CEO & Director
2	Dr. Stephen Hoge M.D.	President
3	Mr. James M. Mock	Chief Financial Officer
4	Ms. Shannon Thyme Klinger J.D.	Chief Legal Officer & Corporate Secretary
5	Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer
6	Ms. Lavina Talukdar CFA	Senior VP & Head of Investor Relations
7	Chris Ridley	VP & Global Head of Communications
8	Ms. Tracey Franklin	Chief People & Digital Technology Officer
9	Dr. Charbel Haber M.P.H., Ph.D.	Senior VP & Head of Global Regulatory Science
10	Mr. Patrick Norman Bergstedt	Senior Vice President of Commercial Vaccines

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	11,44%	6,58 Mrd. USD
2	BlackRock Inc	7,42%	4,27 Mrd. USD
3	Vanguard Capital Management, LLC	5,73%	3,29 Mrd. USD
4	Capital World Investors	5,58%	3,21 Mrd. USD
5	Baillie Gifford & Co Limited.	4,56%	2,62 Mrd. USD
6	Vanguard Portfolio Management, LLC	3,91%	2,25 Mrd. USD
7	State Street Corp	3,72%	2,14 Mrd. USD
8	Geode Capital Management, LLC	2,36%	1,36 Mrd. USD
9	Morgan Stanley - Brokerage Accounts	2,12%	1,22 Mrd. USD
10	Theleme Partners LLP	2,02%	1,16 Mrd. USD
11	Two Sigma Investments LLC	1,80%	1,04 Mrd. USD
12	The Goldman Sachs Group Inc	1,65%	0,95 Mrd. USD
13	Amvescap Plc.	1,20%	0,69 Mrd. USD
14	Charles Schwab Investment Management Inc	1,19%	0,68 Mrd. USD
15	Flagship Ventures Management, Inc.	1,16%	0,67 Mrd. USD
16	UBS Group AG	1,10%	0,64 Mrd. USD
17	BNP Paribas Arbitrage, SA	1,08%	0,62 Mrd. USD
18	Alyeska Investment Group, L.P.	1,01%	0,58 Mrd. USD
19	NORGES BANK	0,76%	0,44 Mrd. USD
20	Northern Trust Corp	0,74%	0,43 Mrd. USD